Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | CYP24A1 | Q07973 | 4/20 | 0.56 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21419663 | 0.90 | CYP19A1 (0.56) | CYP19A1KMT2ACYP24A1CYP26A1RAB9A | |
| SCHEMBL20390011 | 0.89 | CYP19A1 (0.54) | CYP19A1KMT2ACYP24A1CYP26A1CYP17A1 | |
| SCHEMBL18123005 | 0.88 | CYP19A1 (0.59) | CYP19A1KMT2ACYP24A1CYP26A1RAB9A | |
| SCHEMBL20830319 | 0.88 | CYP19A1 (0.59) | CYP19A1KMT2ACYP24A1CYP26A1RAB9A | |
| SCHEMBL20390014 | 0.88 | CYP17A1 (0.51) | CYP19A1KMT2ACYP24A1CYP26A1RAB9A | |
| SCHEMBL22241533 | 0.87 | CYP19A1 (0.58) | CYP19A1KMT2ACYP24A1CYP26A1RAB9A | |
| SCHEMBL19054884 | 0.87 | MAPT (0.56) | CYP24A1CYP26A1RAB9AMAPTCYP17A1 | |
| SCHEMBL20390008 | 0.86 | MAPT (0.47) | CYP19A1KMT2ACYP24A1CYP26A1RAB9A | |
| SCHEMBL21419653 | 0.82 | CYP19A1 (0.47) | CYP19A1KMT2ACYP24A1CYP26A1RAB9A | |
| SCHEMBL22241536 | 0.81 | CYP19A1 (0.46) | CYP19A1KMT2ACYP24A1CYP26A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718587-B2 | Compound, epoxy curing catalyst and method for producing compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-11142629-B2 | Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-10-12 | — | — | US | disclosed |
| US-20200283567-A1 | COMPOUND, EPOXY CURING CATALYST AND METHOD FOR PRODUCING COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-09-10 | — | — | US | disclosed |
| US-10696845-B2 | Energy-sensitive resin composition | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-06-30 | — | — | US | disclosed |
| US-10570269-B2 | Composition containing microparticles | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-02-25 | — | — | US | disclosed |
| US-20190300674-A1 | HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-10-03 | — | — | US | disclosed |
| US-10364372-B2 | Composition and method of producing siliceous film | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-07-30 | — | — | US | disclosed |
| US-20190225804-A1 | ENERGY-SENSITIVE RESIN COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-07-25 | — | — | US | disclosed |
| EP-3514145-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2019-07-24 | — | — | EP | disclosed |
| US-10336708-B2 | Imidazole compound, metal surface treatment liquid, metal surface treatment method, and laminate production method | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-07-02 | — | — | US | disclosed |
| US-20180201807-A1 | COMPOSITION AND METHOD OF PRODUCING SILICEOUS FILM | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-07-19 | — | — | US | disclosed |
| US-20180201807-A1 | COMPOSITION AND METHOD OF PRODUCING SILICEOUS FILM | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-07-19 | — | — | US | disclosed |
| US-20180194930-A1 | COMPOSITION CONTAINING MICROPARTICLES | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-07-12 | — | — | US | disclosed |
| US-20180194930-A1 | COMPOSITION CONTAINING MICROPARTICLES | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-07-12 | — | — | US | disclosed |
| US-20170247334-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-08-31 | — | — | US | disclosed |
| US-20170247334-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-08-31 | — | — | US | disclosed |
| EP-3184511-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2017-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10336708-B2 | Imidazole compound, metal surface treatment liquid, metal surface treatment method, and laminate production method | FASN, SLC27A1, SLC27A2 | CYP19A1 1211/4885KMT2A 1187/4885CYP24A1 1784/4885 |
| US-20180194930-A1 | COMPOSITION CONTAINING MICROPARTICLES | CHMP4B, EXOSC10, EXOSC9 | CYP19A1 4154/4885KMT2A 3532/4885CYP24A1 3200/4885 |
| US-20200283567-A1 | COMPOUND, EPOXY CURING CATALYST AND METHOD FOR PRODUCING COMPOUND | MSMO1, RIOK1, ME1 | CYP19A1 396/4885KMT2A 1027/4885CYP24A1 2215/4885 |
| US-20170247334-A1 | IMIDAZOLE COMPOUND, METAL SURFACE TREATMENT LIQUID, METAL SURFACE TREATMENT METHOD, AND LAMINATE PRODUCTION METHOD | FASN, SLC27A1, SLC27A2 | CYP19A1 1211/4885KMT2A 1187/4885CYP24A1 1784/4885 |
| US-11718587-B2 | Compound, epoxy curing catalyst and method for producing compound | MSMO1, RIOK1, ME1 | CYP19A1 396/4885KMT2A 1027/4885CYP24A1 2215/4885 |
| US-10570269-B2 | Composition containing microparticles | CHMP4B, EXOSC10, EXOSC9 | CYP19A1 4154/4885KMT2A 3532/4885CYP24A1 3200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.